Inspira Technologies Oxy B.H.N. Ltd. (IINN) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
Address
2 Ha-Tidhar Street
Raanana, 4366504
Israel
Phone
972 9 966 4488
Sector
Healthcare
Industry
Medical - Devices
Employees
37
First IPO Date
July 14, 2021
| Name | Title | Pay | Year Born |
| Dagi Shahar Ben-Noon | Co-Founder, Chief Executive Officer & Director | 359,037 | 1976 |
| Daniella Yeheskely-Hayon | Chief Technology Officer | 261,624 | 1977 |
| Yafit Tehila | Chief Financial Officer | 269,693 | 1981 |
| Avi Shabtai | Chief Operating Officer and Vice President of Research & Development | 344,302 | 1974 |
| Adi Shmueli | Director of Marketing | 0 | N/A |
| Sivan Ozeri | Administrative Manager | 0 | N/A |
| Yoav Rozanovich | Chief Business Officer | 0 | N/A |
| Mike Hershkovitz | Vice President of Global Sales | 0 | N/A |
Inspira Technologies Oxy B.H.N. Ltd. is a specialized medical device firm focused on developing, producing, and commercializing respiratory support systems. These systems offer a less invasive alternative to mechanical ventilation (MV) for patients suffering from respiratory failure. Its flagship offering is the Augmented Respiration Technology (ART) system, an innovative respiratory assistance device. The ART system employs a portable, minimally invasive dual-lumen cannula, which is strategically placed in the jugular vein to facilitate extracorporeal direct blood oxygenation, thereby effectively boosting and stabilizing critically low oxygen saturation levels. The company operated under the name Insense Medical Ltd. before rebranding as Inspira Technologies Oxy B.H.N. Ltd. in July 2020. Established in 2018, Inspira Technologies maintains its headquarters in Ra'annana, Israel.